News
11-02-2023, 07:03 AM
The safety and efficacy of treating human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer with pyrotinib.
More... (https://www.news-medical.net/news/20231102/New-treatment-breakthrough-Pyrotinib-combo-demonstrates-remarkable-efficacy-for-HER2-positive-metastatic-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20231102/New-treatment-breakthrough-Pyrotinib-combo-demonstrates-remarkable-efficacy-for-HER2-positive-metastatic-breast-cancer.aspx)